Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19
暂无分享，去创建一个
C. Aguilar-Salinas | A. Ruiz-Margáin | F. Cubero | Y. Nevzorova | A. Gulias-Herrero | B. M. Román-Calleja | Paulina Moreno-Guillén | J. A. González-Regueiro | Deyanira Kúsulas-Delint | A. Campos-Murguía | R. Macías-Rodríguez | Mariana Cruz-Contreras | M. Chapa-Ibargüengoitia | O. Lozano-Cruz | A. A. Solís-Ortega | Israel Vicente Toledo-Coronado | Carlos Fernando Martínez-Cabrera | Nabila Cruz-Yedra | R. Macías‐Rodríguez